Skip to main content
Tavish Nanda, MD, Ophthalmology, Hartford, CT, Hartford Hospital

TavishNandaMD

Ophthalmology Hartford, CT

Retinal Disease, Uveitis, Ocular Oncology

Vitreoretinal Surgeon

Dr. Nanda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nanda's full profile

Already have an account?

Summary

  • Dr. Tavish Nanda is a vitreoretinal specialist in Hartford, CT. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons. Dr. Nanda completed residency training at Columbia University in New York City, where he served as chief resident, followed by a two-year combined vitreoretinal surgery fellowship with the renowned New England Eye Center / Ophthalmic Consultants of Boston program.

    He specializes in retinal disease, uveitis, and ocular oncology and has experience with complex surgical conditions from tractional detachments to secondary IOLs. He is board certified in ophthalmology, and has been active on the national and international level, with more than 50 publications and presentations. During fellowship he also served as a sub-investigator for over two dozen clinical trials, including Vabysmo and Syfovre.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Ophthalmology, 2018 - 2021
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2017

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2021 - 2025
  • CT State Medical License
    CT State Medical License 2023 - 2024
  • American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • More Than a Third of Inpatients Don't Receive Their Anti-Glaucoma Drugs
    More Than a Third of Inpatients Don't Receive Their Anti-Glaucoma DrugsJuly 12th, 2019

Hospital Affiliations